by Corina Milic | Aug 25, 2021
The report provides market intelligence on hepatitis C (HCV) diagnostics and drugs in low- and middle-income countries to help guide elimination of the disease. It also covers preliminary insights into the hepatitis B (HBV) market. We are pleased to release the second...
by Corina Milic | Aug 16, 2021
CHAI is pleased to share news today from MedAccess of measures to increase access to a patient-friendly preventative therapy for tuberculosis (TB). The volume guarantee agreement between MedAccess and Macleods Pharmaceuticals, in partnership with CHAI and...
by Scott Miller | Aug 4, 2021
We were shocked and saddened to learn today that CHAI’s Board Chair, Dr. Tachi Yamada, has passed away. Tachi has been a driving force in global health for decades and his loss will be felt around the world. As a physician, professor, mentor, and leader of large and...
by Corina Milic | Jul 25, 2021
Unitaid and the Clinton Health Access Initiative, Inc. (CHAI) announce pricing agreement with pharmaceutical company Hetero Labs LTD to make available generic version of best-in-class second-line therapy for people living with HIV. July 26, 2021 – Unitaid and CHAI...
by Corina Milic | Jul 19, 2021
A full list of sessions that CHAI is participating in at the Internationl AIDS Society conference. Presentation links will be updated when recordings are available, so check back regularly. Satelitte Sessions Ending cryptococcal meningitis deaths by 2030: Critical but...
by Corina Milic | Jul 13, 2021
July 13, 2021 – The Global Antibiotic Research and Development Partnership (GARDP), the Clinton Health Access Initiative (CHAI) and Shionogi & Co., Ltd today announced a Memorandum of Understanding (MOU) to accelerate access, including in low- and middle-income...
